Jacobs Levy Equity Management, Inc Biomea Fusion, Inc. Transaction History
Jacobs Levy Equity Management, Inc
- $25.8 Billion
- Q4 2024
A detailed history of Jacobs Levy Equity Management, Inc transactions in Biomea Fusion, Inc. stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 197,528 shares of BMEA stock, worth $683,446. This represents 0.0% of its overall portfolio holdings.
Number of Shares
197,528Holding current value
$683,446% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BMEA
# of Institutions
126Shares Held
17.5MCall Options Held
1.8MPut Options Held
1.08M-
Cormorant Asset Management, LP Boston, MA3.57MShares$12.4 Million1.09% of portfolio
-
Black Rock Inc. New York, NY2.34MShares$8.11 Million0.0% of portfolio
-
Baker Bros. Advisors LP New York, NY1.45MShares$5.02 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.4MShares$4.85 Million0.0% of portfolio
-
Aisling Capital Management LP New York, NY799KShares$2.76 Million1.14% of portfolio
About Biomea Fusion, Inc.
- Ticker BMEA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,290,600
- Market Cap $101M
- Description
- Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...